• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation.DNA损伤转导蛋白RNF8通过激活Twist促进癌症化疗耐药性和进展。
Mol Cell. 2016 Sep 15;63(6):1021-33. doi: 10.1016/j.molcel.2016.08.009. Epub 2016 Sep 8.
2
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.微小RNA-300通过靶向人类上皮癌中的Twist蛋白抑制上皮-间质转化和转移。
Mol Cancer. 2014 May 24;13:121. doi: 10.1186/1476-4598-13-121.
3
RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.RNF8促进乳腺癌细胞的上皮-间质转化。
J Exp Clin Cancer Res. 2016 Jun 4;35(1):88. doi: 10.1186/s13046-016-0363-6.
4
YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.YWHAE 促进乳腺癌细胞的增殖、转移和化疗耐药性。
Kaohsiung J Med Sci. 2019 Jul;35(7):408-416. doi: 10.1002/kjm2.12075. Epub 2019 Apr 18.
5
Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.TWIST小干扰RNA和抗癌药物的纳米颗粒递送:一种抗癌治疗方法
Enzymes. 2018;44:83-101. doi: 10.1016/bs.enz.2018.08.004. Epub 2018 Oct 5.
6
Long noncoding RNA ATB promotes the epithelial-mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer.长链非编码 RNA ATB 通过上调 miR-200c/Twist1 轴促进乳腺癌的上皮-间充质转化,并预测乳腺癌的预后不良。
Cell Death Dis. 2018 Dec 5;9(12):1171. doi: 10.1038/s41419-018-1210-9.
7
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.Twist在乳腺癌细胞中转录上调AKT2,导致迁移、侵袭增加以及对紫杉醇耐药。
Cancer Res. 2007 Mar 1;67(5):1979-87. doi: 10.1158/0008-5472.CAN-06-1479.
8
Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.Twist 通过转录上调 ROR1 促进基底样乳腺癌的肿瘤转移。
Theranostics. 2018 Apr 9;8(10):2739-2751. doi: 10.7150/thno.21477. eCollection 2018.
9
LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.长链非编码RNA-Hh通过激活刺猬信号通路增强Twist阳性乳腺癌中的癌症干细胞生成。
Stem Cells. 2016 Jan;34(1):55-66. doi: 10.1002/stem.2219. Epub 2015 Nov 17.
10
Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT.TWIST 敲低通过抑制 MDR1 和 EMT 增强多柔比星耐药 HepG2 细胞中化疗药物的细胞毒性。
Int J Oncol. 2018 Oct;53(4):1763-1773. doi: 10.3892/ijo.2018.4495. Epub 2018 Jul 20.

引用本文的文献

1
KRT80, Regulated by RNF8-Mediated Ubiquitination, Contributes to Glucose Metabolic Reprogramming and Progression of Glioblastoma.由RNF8介导的泛素化调控的KRT80促进胶质母细胞瘤的葡萄糖代谢重编程和进展。
Neurochem Res. 2025 Mar 27;50(2):128. doi: 10.1007/s11064-025-04380-4.
2
TWIST1 regulates HK2 ubiquitination degradation to promote pancreatic cancer invasion and metastasis.TWIST1调节己糖激酶2的泛素化降解以促进胰腺癌的侵袭和转移。
Cancer Cell Int. 2025 Feb 7;25(1):37. doi: 10.1186/s12935-024-03583-z.
3
High C-reactive protein is associated with the efficacy of neoadjuvant chemotherapy for hormone receptor-positive breast cancer.高 C 反应蛋白与激素受体阳性乳腺癌新辅助化疗的疗效相关。
Medicine (Baltimore). 2024 Nov 29;103(48):e40775. doi: 10.1097/MD.0000000000040775.
4
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review).乐伐替尼在晚期肝细胞癌中的临床应用作用及其耐药机制(综述)
Am J Cancer Res. 2024 Sep 15;14(9):4113-4171. doi: 10.62347/UJVP4361. eCollection 2024.
5
Increased DNA damage of adipose tissue-derived mesenchymal stem cells under inflammatory conditions.炎症条件下脂肪组织来源间充质干细胞的DNA损伤增加。
Heliyon. 2024 Aug 20;10(17):e36275. doi: 10.1016/j.heliyon.2024.e36275. eCollection 2024 Sep 15.
6
Key chromatin regulator-related genes associated with the risk of coronary artery disease regulate the expression of HCFC1, RNF8, TNP1 and SET.与冠状动脉疾病风险相关的关键染色质调节因子相关基因调控HCFC1、RNF8、TNP1和SET的表达。
Heliyon. 2024 Mar 29;10(7):e28685. doi: 10.1016/j.heliyon.2024.e28685. eCollection 2024 Apr 15.
7
The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer.泛素化与结直肠癌化疗耐受的串扰。
J Cancer Res Clin Oncol. 2024 Mar 23;150(3):154. doi: 10.1007/s00432-024-05659-9.
8
Hyperoside Inhibits RNF8-mediated Nuclear Translocation of β-catenin to Repress PD-L1 Expression and Prostate Cancer.金丝桃苷抑制 RNF8 介导的β-连环蛋白核转位以抑制 PD-L1 表达并抑制前列腺癌。
Anticancer Agents Med Chem. 2024;24(6):464-476. doi: 10.2174/0118715206289246240110044931.
9
SiRNF8 Delivered by DNA Framework Nucleic Acid Effectively Sensitizes Chemotherapy in Colon Cancer.DNA 框架核酸递呈的 SirnF8 有效增强结肠癌的化疗敏感性。
Int J Nanomedicine. 2024 Jan 6;19:171-188. doi: 10.2147/IJN.S437859. eCollection 2024.
10
Zooming into the structure-function of RING finger proteins for anti-cancer therapeutic applications.深入研究环状指蛋白的结构功能以用于抗癌治疗应用。
Am J Cancer Res. 2023 Jul 15;13(7):2773-2789. eCollection 2023.

本文引用的文献

1
AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation.AKT1通过磷酸化依赖性的Twist1降解抑制乳腺癌中的上皮-间质转化。
Cancer Res. 2016 Mar 15;76(6):1451-62. doi: 10.1158/0008-5472.CAN-15-1941. Epub 2016 Jan 12.
2
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.上皮-间质转化并非肺转移所必需,但会导致化疗耐药。
Nature. 2015 Nov 26;527(7579):472-6. doi: 10.1038/nature15748. Epub 2015 Nov 11.
3
Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage.组蛋白 H1 可将泛素信号的起始和扩增偶联起来,以应对 DNA 损伤。
Nature. 2015 Nov 19;527(7578):389-93. doi: 10.1038/nature15401. Epub 2015 Oct 21.
4
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.浸润性小叶乳腺癌的综合分子图谱
Cell. 2015 Oct 8;163(2):506-19. doi: 10.1016/j.cell.2015.09.033.
5
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.上皮-间质可塑性:癌症进展的核心调节因子
Trends Cell Biol. 2015 Nov;25(11):675-686. doi: 10.1016/j.tcb.2015.07.012. Epub 2015 Oct 1.
6
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.单细胞分析揭示了人类转移性乳腺癌细胞中的干细胞程序。
Nature. 2015 Oct 1;526(7571):131-5. doi: 10.1038/nature15260. Epub 2015 Sep 23.
7
The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.CBM复合物通过承保NF-κB激活来促进HER2相关肿瘤的恶性进展。
Mol Cancer Res. 2016 Jan;14(1):93-102. doi: 10.1158/1541-7786.MCR-15-0229-T. Epub 2015 Sep 21.
8
Targeting Mdmx to treat breast cancers with wild-type p53.靶向Mdmx治疗具有野生型p53的乳腺癌。
Cell Death Dis. 2015 Jul 16;6(7):e1821. doi: 10.1038/cddis.2015.173.
9
Expression of EMT Markers SLUG and TWIST in Breast Cancer.上皮-间质转化标志物SLUG和TWIST在乳腺癌中的表达
Anticancer Res. 2015 Jul;35(7):3961-8.
10
Non-histone protein methylation as a regulator of cellular signalling and function.非组蛋白蛋白甲基化作为细胞信号转导和功能的调节剂。
Nat Rev Mol Cell Biol. 2015 Jan;16(1):5-17. doi: 10.1038/nrm3915. Epub 2014 Dec 10.

DNA损伤转导蛋白RNF8通过激活Twist促进癌症化疗耐药性和进展。

The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation.

作者信息

Lee Hong-Jen, Li Chien-Feng, Ruan Diane, Powers Scott, Thompson Patricia A, Frohman Michael A, Chan Chia-Hsin

机构信息

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA; Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA.

National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan; Department of Pathology, Chi-Mei Foundational Medical Center, Tainan 710, Taiwan.

出版信息

Mol Cell. 2016 Sep 15;63(6):1021-33. doi: 10.1016/j.molcel.2016.08.009. Epub 2016 Sep 8.

DOI:10.1016/j.molcel.2016.08.009
PMID:27618486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5026628/
Abstract

Twist has been shown to cause treatment failure, cancer progression, and cancer-related death. However, strategies that directly target Twist are not yet conceivable. Here we reveal that K63-linked ubiquitination is a crucial regulatory mechanism for Twist activation. Through an E3 ligase screen and biochemical studies, we unexpectedly identified that RNF8 functions as a direct Twist activator by triggering K63-linked ubiquitination of Twist. RNF8-promoted Twist ubiquitination is required for Twist localization to the nucleus for subsequent EMT and CSC functions, thereby conferring chemoresistance. Our histological analyses showed that RNF8 expression is upregulated and correlated with disease progression, EMT features, and poor patient survival in breast cancer. Moreover, RNF8 regulates cancer cell migration and invasion and cancer metastasis, recapitulating the effect of Twist. Together, our findings reveal a previously unrecognized tumor-promoting function of RNF8 and provide evidence that targeting RNF8 is an appealing strategy to tackle tumor aggressiveness and treatment resistance.

摘要

Twist已被证明会导致治疗失败、癌症进展和癌症相关死亡。然而,直接靶向Twist的策略目前还难以想象。在此我们揭示,K63连接的泛素化是Twist激活的关键调控机制。通过E3连接酶筛选和生化研究,我们意外发现RNF8通过触发Twist的K63连接泛素化而作为直接的Twist激活因子发挥作用。RNF8促进的Twist泛素化是Twist定位于细胞核以实现随后的上皮-间质转化(EMT)和癌症干细胞(CSC)功能所必需的,从而赋予化学抗性。我们的组织学分析表明,在乳腺癌中,RNF8表达上调且与疾病进展、EMT特征以及患者不良生存相关。此外,RNF8调节癌细胞迁移、侵袭和癌症转移,重现了Twist的作用。总之,我们的研究结果揭示了RNF8此前未被认识到的促肿瘤功能,并提供证据表明靶向RNF8是应对肿瘤侵袭性和治疗抗性的一种有吸引力的策略。